Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Late Breaking Poster Session

New Prebiotics to Ameliorate High-Fat Diet-Induced Obesity and Diabetes via Modulation of Microbiome-Gut-Brain Axis

  1. SHOKOUH AHMADI,
  2. RAVINDER K. NAGPAL,
  3. SHAOHUA WANG and
  4. HARIOM YADAV
  1. Winston-Salem, NC
Diabetes 2018 Jul; 67(Supplement 1): -. https://doi.org/10.2337/db18-264-LB
Previous
  • Article
  • Info & Metrics
Loading

Abstract

Role of gut microbiome in obesity and diabetes became apparent from several independent studies, indicating that gut microbiome modulators like prebiotics may improve microbiome perturbations (dysbiosis) to ameliorate metabolic derangements. We isolated water soluble, non-digestible polysaccharides from 5 foods (acorn, quinoa, sunflower, pumpkin and sago seeds) and assessed their impact on amelioration of high fat diet (HFD)-induced obesity and diabetes in mice and human microbiome using fecal slurry culture model. During isolation, purification, biochemical and digestion resistance characterization, and fermentation pattern by human fecal microbiome, we selected acorn and sago derived prebiotics, on the basis of purity, protein contamination and yield. All prebiotics increased short chain fatty acid (SCFA) production along with enhanced microbial diversity. Feeding of acorn and sago derived prebiotics supplemented HFD (5%) for 8 weeks, significantly reduced diet induced glucose intolerance and insulin resistance, without affecting adiposity. Beneficial effects of acorn and sago derived prebiotics were superior than inulin-feeding. Feeding of both prebiotics and inulin increased diversity of gut microbiome and enhanced SCFA production into the mice gut. Metabolic function was positively correlated with increased food conversion ratio indicating enhanced whole body metabolic rate by prebiotic feeding. Gastrointestinal motility was enhanced without changing food intake, after probiotic intervention. Hypothalamic energy signaling in terms of increased pro-opiomelanocortin and decreased agouti-related peptide and neuropeptide Y expression, was modulated by prebiotics administration. These results indicate that newly isolated prebiotics ameliorate HFD-induced defects of glucose metabolism via modulating microbiome-gut-brain axis, and can be used to prevent/treat diet induced obesity and diabetes.

Disclosure S. Ahmadi: None. R.K. Nagpal: None. S. Wang: None. H. Yadav: None.

  • © 2018 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

Previous
Back to top
Diabetes: 67 (Supplement 1)

In this Issue

July 2018, 67(Supplement 1)
  • Table of Contents
  • Index by Author
  • Abstract PDFs
Sign up to receive current issue alerts
View Selected Citations (0)
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
New Prebiotics to Ameliorate High-Fat Diet-Induced Obesity and Diabetes via Modulation of Microbiome-Gut-Brain Axis
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
New Prebiotics to Ameliorate High-Fat Diet-Induced Obesity and Diabetes via Modulation of Microbiome-Gut-Brain Axis
SHOKOUH AHMADI, RAVINDER K. NAGPAL, SHAOHUA WANG, HARIOM YADAV
Diabetes Jul 2018, 67 (Supplement 1) 264-LB; DOI: 10.2337/db18-264-LB

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

New Prebiotics to Ameliorate High-Fat Diet-Induced Obesity and Diabetes via Modulation of Microbiome-Gut-Brain Axis
SHOKOUH AHMADI, RAVINDER K. NAGPAL, SHAOHUA WANG, HARIOM YADAV
Diabetes Jul 2018, 67 (Supplement 1) 264-LB; DOI: 10.2337/db18-264-LB
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics

Related Articles

Cited By...

More in this TOC Section

Late Breaking Poster Session

  • Pancreatic Alpha-Cell Function and Identity in Human T2D
  • Lactogens Prevent ER Stress-Induced ß-Cell Death and Diabetes
  • Pancreatic ß-Cell Specific Knockout of Grb10 Improves ß-Cell Function by Enhancing ß-Cell Differentiation and Suppressing ß-Cell Dedifferentiation
Show more Late Breaking Poster Session

Integrated Physiology/Obesity

  • Betatrophin Is Associated with Type 2 Diabetes and Markers of Insulin Resistance
  • Insulin Resistance and Weight Loss in Obese Women with Polycystic Ovary Syndrome Treated with Liraglutide—Single Institution Experience
  • Association between IGF1/IGFBP3 with Lipid Metabolism and Chronic Low-Grade Inflammation and Alteration after Laparoscopic Sleeve Gastrectomy in Chinese Obese Subjects
Show more Integrated Physiology/Obesity

Integrated Physiology–Macronutrient Metabolism and Food Intake

  • MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, Acutely Inhibits Food Intake in Leptin-Deficient ob/ob Mice and Leptin Receptor–Deficient fa/fa Rats
  • Effects of Sucrose vs. Fructose-and-Glucose Intakes on Gut Abundance of Akkermansia Muciniphila and Serum Kidney Injury Molecule-1 in Rats
  • Relating Disinhibited Eating Behaviors to Resting State Functional Connectivity in Young Children
Show more Integrated Physiology–Macronutrient Metabolism and Food Intake

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.